Schellingerhout Laboratory
Dawid Schellingerhout, M.D.
Principal Investigator
Cancer Systems Imaging
Associate Professor
Areas of Research
- Imaging
The research of Dawid Schellingerhout, M.D., centers on investigating the nervous system with molecular and novel imaging technologies. His group has developed a set of molecular imaging agents for neurography, the imaging of nerve tissue by means of molecular imaging, and has investigated several preclinical models in preparation to applying this technology to humans.
Dr. Schellingerhout also has a patient-centered program investigating the correlations between imaging and biological findings in patients with gliomas, in collaboration with Neurosurgery and Neuropathology, and involving advanced MR imaging directed biopsies correlated to state-of-the-art pathological and biological assessments of harvested patient brain tissues. He is also investigating the clinical uses of Dual Energy CT and Phase Sensitive MR in the characterization of cerebral lesions in a human imaging trial.
Grants
Current
Principal Investigator, (0%). Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies, DICRC-04-2010, Diagnostic Imaging Clinical Research Committee, 1/1/2011-present
Principal Investigator, (13%). Molecular Imaging of Retrograde Nerve Transport, 5 R01 NS070742 02, NIH/NINDS, 3/1/2011-2/28/2016
Principal Investigator, (0%). Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies, MDA Clinical Research Finance Molecular Evaluation and Biopsy Related Support, 2012-present
Principal Investigator, (0%) A New Treatment for Brain Tumors: Targeting Tumor Metabolism with Glucose-based Therapeutic Agents and Monitoring Treatment Response with Hyperpolarized MR-Spectroscopy Recently appointed PI/Coordinator following the departure of Dr. Conrad, after re-writing of the project as: “Targeting the Glycolytic Pathway in the Therapy of Glioma, with Imaging Feedback of Efficacy by Means of Hyperpolarized MR Spectroscopy", Rose Foundation, 7/2014
Principal Investigator, (0%). Radiologic-Pathologic Correlation on Stereotactic Biopsies in Glioma Patients. Total funding: $50,000. Oct 2014 – Oct 2015 (Submitted October 1, 2014, Funded December 11, 2014), MDA IRG Patient Oriented Award, 12/11/2014
Collaborator, Development of Unconventional MRI Approaches to Imaging Cancer Immunotherapy. (0% support). $200,000 over 2 years. Awarded Aug 17, 2015, CABI MI2 (Bankson/Sokolov), 8/17/2015
Principal Investigator, (0%), Laurence Court, Amol Ghia. Predicting Radiation-Induced Cord Myelopathy Using a Molecular Imaging Readout of Retrograde Axonal Transport to Predict Myelopathy. Total funding: $60,000, 9/1/2015 to 8/31/2016 (6 month extension possible). Invited to submit full proposal 7/28/2015, awarded 9/1/2015, CROR (Center for Radiation Oncology Research Seed Funding Program), 9/1/2015, NCE
Principal Investigator, (10%). Co-PI: Dianna Cody Hemorrhagic versus Calcific Brain Lesion Study Direct costs $487,589, Total costs $581,037 over 2 years. 10/1/2015 – 9/30/2017 (GE signed work order 9/9/2015) (IRB approved Oct 14, 2015), CABI GE Healthcare Award, 10/14/2015
Completed
Principal Investigator, (0% effort funded). Bridge Funding: Molecular Imaging of Retrograde Nerve Transport, The University of Texas MD Anderson Cancer Center, 7/2010-1/2012
Principal Investigator, (2% effort). Molecular Imaging of Treatments for Oxaliplatin Neurotoxicity, 05-05-04032, The Mike Hogg Fund, 1/1/2011-6/30/2012
Co-Investigator, (0% support). Characterization of Calcium and Iron Solutions using Gemstone Spectral Imaging CT to distinguish between Hemorrhagic and Calcific Lesions, Center for Advanced Biomedical Imaging, PI - Dianne Cody, 7/2012-7/2014
Co-Investigator, Reducing the Impact of Chemotherapy-Induced Neuropathies on Cancer Patients: Understanding the Molecular Mechanisms of Disease, Mike Hogg Fund, 10/2013-1/2014
Principal Investigator, (0% support). Molecular Neurographic Imaging to Preserve Genital Nerve Function in Prostate Cancer, MDACC-Washington University p50 Molecular Imaging Center Pilot Project Program, 2/1/2014-12/31/2014
Co-Investigator, Preserving Genital Nerve Function in Prostate Cancer: Imaging with a Molecular Imaging Agent, M D Anderson Minimally Invasive and New Technology in Oncologic Surgery, 2/2014-4/30/2015
Related Links
Contact
The University of Texas MD Anderson Cancer Center
Cancer Systems Imaging
1881 East Road
Unit Number: 1907
Houston, TX 77054-1901
Room Number: 3SCR4.3614
Phone: 713-794-5216
Fax: 713-794-5456
Email: Dawid.Schellingerhout@mdanderson.org